精子冷冻保存不影响正常精液男性活产率:7969个卵母细胞捐赠周期分析
该回顾性队列纳入2013年1月至2019年12月单中心7969对首次卵母细胞捐赠周期夫妇,均用男方正常精液行选择性ICSI。新鲜精组2865周期、冷冻精组5104周期,校正混杂后冷冻精不影妊娠与活产,仅受精率略低(74.65% vs 73.66%,P=0.0334)。
要点
- 正常精液男性冷冻精行ICSI,校正后活产率与新鲜精无显著差异(OR 1.082,P=0.1805)。
- 冷冻精组受精率略低于新鲜精组(73.66% vs 74.65%,P=0.0334),作者认为无临床意义。
- 生化妊娠新鲜精几率较高(OR 1.143,P=0.0175),持续妊娠无显著差异(OR 1.101,P=0.0983)。
核心结论
- 在校正混杂因素后,正常精液男性使用冷冻精行选择性ICSI不影响妊娠率和活产率。
- 冷冻精可能轻微降低受精率,但作者认为无临床相关性。
研究设计与样本
- 回顾性队列研究,纳入2013年1月至2019年12月单中心7969对首次卵母细胞捐赠周期夫妇。
- 所有周期均行选择性ICSI、新鲜卵母细胞和新鲜胚胎移植(卵裂期或囊胚期)。
- 按精液状态分两组:新鲜精组n=2865,冷冻精组n=5104。
主要发现
- 新鲜精组与冷冻精组男方和女方年龄、射精后精子浓度和活力、授精卵母细胞数相似。
- Student t检验示两组受精率无显著差异(P=0.0591);校正混杂后差异达统计学显著:新鲜精74.65%(95%CI 73.92-75.38)vs 冷冻精73.66%(95%CI 73.11-74.20),P=0.0334。
- 校正回归分析示新鲜精生化妊娠几率较高(OR 1.143,P=0.0175)。
- 持续妊娠(OR 1.101,P=0.0983)和活产(OR 1.082,P=0.1805)无显著影响。
临床怎么用
- 作者结论认为,正常精液男性使用冷冻精不影响妊娠和活产率,是安全且便利的技术。
局限性
- 结果外推至其他精子冷冻保存和选择方案、IVM、高龄产妇和经典IVF周期需谨慎,这些均被排除分析。
- 由于研究为回顾性,某些未控制变量可能影响结果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: Does sperm cryopreservation influence the reproductive outcomes of normozoospermic patients in oocyte donation cycles? SUMMARY ANSWER: After controlling for confounders, the use of cryopreserved semen from normozoospermic patients does not affect pregnancy and live birth rates after elective ICSI. WHAT IS KNOWN ALREADY: Sperm cryopreservation by slow freezing is a common practice in ART. While frozen-thawed semen typically presents reduced motility and vitality, its use for ICSI is generally considered adequate in terms of reproductive outcomes. Nevertheless, most studies comparing reproductive outcomes between fresh and cryopreserved sperm include patients with severe male factor (testicular sperm, oligo-, and/or asthenozoospermia) or women of advanced maternal age, where the altered quality of the gametes can partially mask the full effect of freezing/thawing. STUDY DESIGN, SIZE, DURATION: The study included a retrospective cohort of 7969 couples undergoing their first oocyte donation cycle between January 2013 and December 2019 in one large clinic, using normozoospermic semen from the male partner. All cycles involved elective ICSI, fresh oocytes, and a fresh embryo transfer, either at cleavage or blastocyst stage. Two study groups were established based on the sperm status: fresh (n = 2865) and cryopreserved (n = 5104). PARTICIPANTS/MATERIALS, SETTING, METHODS: A slow freezing protocol was used for all sperm cryopreservation. Sperm washing, capacitation, and selection prior to ICSI were performed identically for fresh and frozen-thawed samples, using pellet swim-up. Fertilization rate (FR), pregnancy (biochemical and ongoing), and live birth rates were compared between study groups using univariate and multivariate regression analyses. MAIN RESULTS AND THE ROLE OF CHANCE: Male and female age, sperm concentration and motility after ejaculation, and number of oocytes inseminated were similar between cycles using fresh or cryopreserved sperm. Analysis by Student's t-test did not indicate a significant difference in FR between fresh and cryopreserved sperm (P = 0.0591); however, after adjusting for confounders, this difference reached statistical significance: 74.65% FR for fresh (CI 95%: 73.92-75.38) versus 73.66% for cryopreserved sperm (CI 95%: 73.11-74.20), P = 0.0334. The adjusted regression analysis revealed higher odds of biochemical pregnancy when using fresh sperm (odds ratio (OR): 1.143, P = 0.0175), but no significant effects of sperm cryopreservation were observed for ongoing pregnancy (OR: 1.101, P = 0.0983) and live birth (OR: 1.082, P = 0.1805). LIMITATIONS, REASONS FOR CAUTION: Caution should be exerted when extrapolating these results to different protocols for sperm cryopreservation and selection, or to IVM, advanced maternal age and classical IVF cycles, which were excluded from analysis. Owing to the retrospective nature of the study, some uncontrolled for variables may affect the results. WIDER IMPLICATIONS OF THE FINDINGS: Sperm cryopreservation does not affect pregnancy and live birth rates in normozoospermic patients, and although it may lower FR s slightly, this would not be clinically relevant. In line with previous studies that included patients with an apparent male or female factor, sperm cryopreservation is a safe and convenient technique. STUDY FUNDING/COMPETING INTEREST(S): The study received no external funding and all authors have no conflicts of interest to declare. TRIAL REGISTRATION NUMBER: N/A.
引用
- Torra-Massana M, Vassena R, Rodríguez A, et al. Sperm cryopreservation does not affect live birth rate in normozoospermic men: analysis of 7969 oocyte donation cycles. Hum Reprod. 2023. PMID: 36661036. doi:10.1093/humrep/dead005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。